The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.
<h4>Background</h4>Most individuals developing tuberculosis (TB) are working age adults living in low- and middle-income countries (LMICs). The resulting disability and death impact economic productivity and burden health systems. New TB vaccine products may reduce this burden. In this s...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2023-07-01
|
| Series: | PLoS Medicine |
| Online Access: | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004252&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846127113479913472 |
|---|---|
| author | Allison Portnoy Jean-Louis Arcand Rebecca A Clark Chathika K Weerasuriya Christinah Mukandavire Roel Bakker Edith Patouillard Nebiat Gebreselassie Matteo Zignol Mark Jit Richard G White Nicolas A Menzies |
| author_facet | Allison Portnoy Jean-Louis Arcand Rebecca A Clark Chathika K Weerasuriya Christinah Mukandavire Roel Bakker Edith Patouillard Nebiat Gebreselassie Matteo Zignol Mark Jit Richard G White Nicolas A Menzies |
| author_sort | Allison Portnoy |
| collection | DOAJ |
| description | <h4>Background</h4>Most individuals developing tuberculosis (TB) are working age adults living in low- and middle-income countries (LMICs). The resulting disability and death impact economic productivity and burden health systems. New TB vaccine products may reduce this burden. In this study, we estimated the impact of introducing novel TB vaccines on gross domestic product (GDP) growth in 105 LMICs.<h4>Methods and findings</h4>We adapted an existing macroeconomic model to simulate country-level GDP trends between 2020 and 2080, comparing scenarios for introduction of hypothetical infant and adolescent/adult vaccines to a no-new-vaccine counterfactual. We parameterized each scenario using estimates of TB-related mortality, morbidity, and healthcare spending from linked epidemiological and costing models. We assumed vaccines would be introduced between 2028 and 2047 and estimated incremental changes in GDP within each country from introduction to 2080, in 2020 US dollars. We tested the robustness of results to alternative analytic specifications. Both vaccine scenarios produced greater cumulative GDP in the modeled countries over the study period, equivalent to $1.6 (95% uncertainty interval: $0.8, 3.0) trillion for the adolescent/adult vaccine and $0.2 ($0.1, 0.4) trillion for the infant vaccine. These GDP gains were substantially lagged relative to the time of vaccine introduction, particularly for the infant vaccine. GDP gains resulting from vaccine introduction were concentrated in countries with higher current TB incidence and earlier vaccine introduction. Results were sensitive to secular trends in GDP growth but relatively robust to other analytic assumptions. Uncertain projections of GDP could alter these projections and affect the conclusions drawn by this analysis.<h4>Conclusions</h4>Under a range of assumptions, introducing novel TB vaccines would increase economic growth in LMICs. |
| format | Article |
| id | doaj-art-c05dd181e1f84e7cb5fd5e5ebc0e3787 |
| institution | Kabale University |
| issn | 1549-1277 1549-1676 |
| language | English |
| publishDate | 2023-07-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS Medicine |
| spelling | doaj-art-c05dd181e1f84e7cb5fd5e5ebc0e37872024-12-12T05:30:53ZengPublic Library of Science (PLoS)PLoS Medicine1549-12771549-16762023-07-01207e100425210.1371/journal.pmed.1004252The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study.Allison PortnoyJean-Louis ArcandRebecca A ClarkChathika K WeerasuriyaChristinah MukandavireRoel BakkerEdith PatouillardNebiat GebreselassieMatteo ZignolMark JitRichard G WhiteNicolas A Menzies<h4>Background</h4>Most individuals developing tuberculosis (TB) are working age adults living in low- and middle-income countries (LMICs). The resulting disability and death impact economic productivity and burden health systems. New TB vaccine products may reduce this burden. In this study, we estimated the impact of introducing novel TB vaccines on gross domestic product (GDP) growth in 105 LMICs.<h4>Methods and findings</h4>We adapted an existing macroeconomic model to simulate country-level GDP trends between 2020 and 2080, comparing scenarios for introduction of hypothetical infant and adolescent/adult vaccines to a no-new-vaccine counterfactual. We parameterized each scenario using estimates of TB-related mortality, morbidity, and healthcare spending from linked epidemiological and costing models. We assumed vaccines would be introduced between 2028 and 2047 and estimated incremental changes in GDP within each country from introduction to 2080, in 2020 US dollars. We tested the robustness of results to alternative analytic specifications. Both vaccine scenarios produced greater cumulative GDP in the modeled countries over the study period, equivalent to $1.6 (95% uncertainty interval: $0.8, 3.0) trillion for the adolescent/adult vaccine and $0.2 ($0.1, 0.4) trillion for the infant vaccine. These GDP gains were substantially lagged relative to the time of vaccine introduction, particularly for the infant vaccine. GDP gains resulting from vaccine introduction were concentrated in countries with higher current TB incidence and earlier vaccine introduction. Results were sensitive to secular trends in GDP growth but relatively robust to other analytic assumptions. Uncertain projections of GDP could alter these projections and affect the conclusions drawn by this analysis.<h4>Conclusions</h4>Under a range of assumptions, introducing novel TB vaccines would increase economic growth in LMICs.https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004252&type=printable |
| spellingShingle | Allison Portnoy Jean-Louis Arcand Rebecca A Clark Chathika K Weerasuriya Christinah Mukandavire Roel Bakker Edith Patouillard Nebiat Gebreselassie Matteo Zignol Mark Jit Richard G White Nicolas A Menzies The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. PLoS Medicine |
| title | The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. |
| title_full | The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. |
| title_fullStr | The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. |
| title_full_unstemmed | The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. |
| title_short | The potential impact of novel tuberculosis vaccine introduction on economic growth in low- and middle-income countries: A modeling study. |
| title_sort | potential impact of novel tuberculosis vaccine introduction on economic growth in low and middle income countries a modeling study |
| url | https://journals.plos.org/plosmedicine/article/file?id=10.1371/journal.pmed.1004252&type=printable |
| work_keys_str_mv | AT allisonportnoy thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT jeanlouisarcand thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT rebeccaaclark thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT chathikakweerasuriya thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT christinahmukandavire thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT roelbakker thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT edithpatouillard thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT nebiatgebreselassie thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT matteozignol thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT markjit thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT richardgwhite thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT nicolasamenzies thepotentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT allisonportnoy potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT jeanlouisarcand potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT rebeccaaclark potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT chathikakweerasuriya potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT christinahmukandavire potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT roelbakker potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT edithpatouillard potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT nebiatgebreselassie potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT matteozignol potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT markjit potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT richardgwhite potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy AT nicolasamenzies potentialimpactofnoveltuberculosisvaccineintroductiononeconomicgrowthinlowandmiddleincomecountriesamodelingstudy |